PRKAA2 and ovarian cancer: Since AICAR treatment of ovarian cancer cells in scratch assays exhibited no effect on cell motility over 24 hours (data not shown), this demonstrates further that forced pharmacologic AMPK activation is detrimental to proliferating ovarian cancer cells.